These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22127852)

  • 1. The altered expression of MiR-221/-222 and MiR-23b/-27b is associated with the development of human castration resistant prostate cancer.
    Sun T; Yang M; Chen S; Balk S; Pomerantz M; Hsieh CL; Brown M; Lee GM; Kantoff PW
    Prostate; 2012 Jul; 72(10):1093-103. PubMed ID: 22127852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNA -23b/-27b cluster suppresses the metastatic phenotype of castration-resistant prostate cancer cells.
    Ishteiwy RA; Ward TM; Dykxhoorn DM; Burnstein KL
    PLoS One; 2012; 7(12):e52106. PubMed ID: 23300597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNA-221 and microRNA-222 in androgen-independent prostate cancer cell lines.
    Sun T; Wang Q; Balk S; Brown M; Lee GS; Kantoff P
    Cancer Res; 2009 Apr; 69(8):3356-63. PubMed ID: 19351832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.
    Rice MA; Ishteiwy RA; Magani F; Udayakumar T; Reiner T; Yates TJ; Miller P; Perez-Stable C; Rai P; Verdun R; Dykxhoorn DM; Burnstein KL
    Oncogene; 2016 Sep; 35(36):4752-61. PubMed ID: 26898757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
    Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
    Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
    Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
    Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.
    Goto Y; Kojima S; Nishikawa R; Enokida H; Chiyomaru T; Kinoshita T; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Oncotarget; 2014 Sep; 5(17):7748-59. PubMed ID: 25115396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer.
    Xu B; Wang N; Wang X; Tong N; Shao N; Tao J; Li P; Niu X; Feng N; Zhang L; Hua L; Wang Z; Chen M
    Prostate; 2012 Aug; 72(11):1171-8. PubMed ID: 22161865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer.
    Aktan Ç; Çal Ç; Kaymaz B; Selvi Günel N; Kıpçak S; Özel B; Gündüz C; Şahin Küçükaslan A; Aygüneş Jafari D; Kosova B
    Life Sci; 2022 Jul; 301():120603. PubMed ID: 35508255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
    Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
    Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer.
    Chiyomaru T; Seki N; Inoguchi S; Ishihara T; Mataki H; Matsushita R; Goto Y; Nishikawa R; Tatarano S; Itesako T; Nakagawa M; Enokida H
    Int J Oncol; 2015 Feb; 46(2):487-96. PubMed ID: 25405368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-616 induces androgen-independent growth of prostate cancer cells by suppressing expression of tissue factor pathway inhibitor TFPI-2.
    Ma S; Chan YP; Kwan PS; Lee TK; Yan M; Tang KH; Ling MT; Vielkind JR; Guan XY; Chan KW
    Cancer Res; 2011 Jan; 71(2):583-92. PubMed ID: 21224345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study.
    Hannafon BN; Cai A; Calloway CL; Xu YF; Zhang R; Fung KM; Ding WQ
    BMC Cancer; 2019 Jun; 19(1):642. PubMed ID: 31253120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.
    Aghaee-Bakhtiari SH; Arefian E; Naderi M; Noorbakhsh F; Nodouzi V; Asgari M; Fard-Esfahani P; Mahdian R; Soleimani M
    Tumour Biol; 2015 Jun; 36(6):4203-12. PubMed ID: 25604141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
    Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N
    Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prooncogenic factors miR-23b and miR-27b are regulated by Her2/Neu, EGF, and TNF-α in breast cancer.
    Jin L; Wessely O; Marcusson EG; Ivan C; Calin GA; Alahari SK
    Cancer Res; 2013 May; 73(9):2884-96. PubMed ID: 23338610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.
    Locke JA; Guns ES; Lubik AA; Adomat HH; Hendy SC; Wood CA; Ettinger SL; Gleave ME; Nelson CC
    Cancer Res; 2008 Aug; 68(15):6407-15. PubMed ID: 18676866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the tumor suppressive miRNA-23b/27b cluster is a good prognostic marker in clear cell renal cell carcinoma.
    Ishihara T; Seki N; Inoguchi S; Yoshino H; Tatarano S; Yamada Y; Itesako T; Goto Y; Nishikawa R; Nakagawa M; Enokida H
    J Urol; 2014 Dec; 192(6):1822-30. PubMed ID: 25014580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
    Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
    Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.